Idiotype cascades associated with the CD4-HIV glycoprotein 120 interaction: Immunization with anti-idiotypic antibodies induces anti-anti- idiotypic responses with anti-CD4 specificity and in vitro neutralizing activity

AIDS Research and Human Retroviruses

Volumn 16, Issue 1, 2000, Pages 77-86

  Shearer, Michael H ^a   Dalgleish, Angus G ^b   Chanh, Tranh C ^c   Kennedy, Ronald C ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^c USAMRID   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; GLYCOPROTEIN GP 120; IDIOTYPIC ANTIBODY; MONOCLONAL ANTIBODY; VIRUS GLYCOPROTEIN;

ANIMAL EXPERIMENT; ANTIBODY DETECTION; ARTICLE; BABOON; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNIZATION; NONHUMAN; PRIORITY JOURNAL; SYNCYTIUM; VIRUS ISOLATION; VIRUS NEUTRALIZATION;

ANIMALS; ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODIES, MONOCLONAL; ANTIGENS, CD4; CD4-POSITIVE T-LYMPHOCYTES; EPITOPES, B-LYMPHOCYTE; FEMALE; GIANT CELLS; HIV-1; HUMANS; IMMUNOGLOBULIN IDIOTYPES; MICE; MICE, INBRED BALB C; PAPIO; RABBITS;

EID: 0033988102     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922200309629     Document Type: Article

References (42)

1. 1. Attanasio R and Kennedy RC: Idiotypic cascades associated with the CD4-HIV gp120 interaction: Principles for idiotype-based vaccines. Int Rev Immunol 1990;7:109-119.
2. 2. Jerne NK: Towards a network theory of the immune system. Ann Immunol (Paris) 1974;125C:373-389.
3. 3. Shoenfeld Y, Ferrone S, and Kennedy RC (eds.): Idiotypes in Medicine: Infections, Autoimmunity, and Cancer. Elsevier Science, Amsterdam, The Netherlands, 1997, pp. 1-448.
4. 4. Attanasio R, Allan JS, Anderson SA, Chanh TC, and Kennedy RC: Anti-idiotypic antibody response to monoclonal anti-CD4 preparations in nonhuman primate species. J Immunol 1991;146:507-514.
5. 5. Schick MR and Kennedy RC: Production and characterization of anti-idiotypic antibody reagents. Methods Enzymol 1989;178:36-48.
6. 6. Attanasio R, Allan JS, and Kennedy RC: Monoclonal anti-CD4 as immunoprophylactic agents for human immunodeficiency virus infection. J Infect Dis 1993;168:515-516.
7. 7. Shearer MH, Timanus DK, Benton PA, Lee DR, and Kennedy RC: Cross-clade inhibition of human immunodeficiency virus type 1 primary isolates by monoclonal anti-CD4. J Infect Dis 1998;177: 1727-1729.
8. 8. Lohman KL, Kieber-Emmons T, and Kennedy RC: Molecular Characterization and structural modeling of immunoglobulin variable regions from murine monoclonal antibodies specific for hepatitis B virus surface antigen. Mol Immunol 1993;30:1295-1306.
9. 9. Attanasio R, Dilley D, Buck D, Maino VC, Lohman KL, Kanda P, and Kennedy RC: Structural characterization of a cross-reactive idiotype shared by monoclonal antibodies specific for the human CD4 molecule. J Biol Chem 1991;266:14611-14619.
10. 10. Lohman KL, Attanasio R, Buck D, Carrillo MA, Allan JS, and Kennedy RC: Characteristics of murine monoclonal anti-CD4: Epitope recognition, idiotype expression, and varible region gene sequence. J Immunol 1992;149:3247-3253.
11. 11. Shearer MH, Lanford RL, and Kennedy RC: Monoclonal antiidiotypic antibodies induce humoral immune responses specific for simian virus 40 large tumor antigen in mice. J Immunol 1990;145: 932-939.
12. 12. Wolf H, Warren RQ, Stunz GW, Shuler KR, Kanda P, and Kennedy RC: Fine specificity of the murine antibody response to HIV-1 gp160 determined by synthetic peptides which define selected epitopes. Mol Immunol 1992;29:989-998.
13. 13. Attanasio R, Kanda P, Stunz GW, Buck DW, and Kennedy RC: Anti-peptide reagent identifies a primary-structure-dependent, cross-reactive idiotype expressed on heavy and light chains from a murine monoclonal Anti-CD4. Mol Immunol 1992;30:9-17.
14. 14. Benton PA, Timanus DK, Shearer MH, White GL, Lee DR, and Kennedy RC: Analysis of nonhuman primate peripheral blood mononuclear cells for susceptibility to HIV-1 infection and HIV coreceptor expression. Dev Comp Immunol 1999;23:97-105.
15. 15. Dalgleish AG, Thomson BJ, Chanh TC, Malkovsky M, and Kennedy RC: Neutralization of HIV isolates by anti-idiotypic antibodies which mimic the T4 (CD4) epitope: A potential AIDS vaccine. Lancet 1987;ii:1047-1050.
16. 16. Warren RQ, Wong MT, Melcher GP, Blatt SP, Zapiola I, Bouzas MB, Muchinik G, Anderson SA, and Kennedy RC: Presence of neutralizing antibodies to heterologous human immunodeficiency virus type 1 isolates in sera of infected individuals is not predictive of rate of disease progression. Clin Diag Lab Immunol 1995; 2:400-403.
17. 17. Warren RQ, Anderson SA, Nkya WMMM, Shao JF, Hendrix CW, Melcher GP, Redfield RR, and Kennedy RC: Examination of sera from human immunodeficiency virus type 1 (HIV-1)-infected individuals for antibodies reactive with peptides corresponding to the principal neutralizing determinant of HIV-1 gp120 and for in vitro neutralizing activity. J Virol 1992;66:5210-5215.
18. 18. Wong MT, Warren RQ, Anderson SA, Dolan MJ, Hendrix CW, Blatt SP, Melcher GP, Boswell RN, and Kennedy RC: Longitudinal analysis of the humoral immune response to human immunodeficiency virus type 1 (HIV-1) gp160 epitopes in rapidly progressing and nonprogressing HIV-1-infected subjects. J Infect Dis 1993;168:1523-1527.
19. 19. Dalgleish AG, Beverley PCL, Clapham PR, Crawford DH, Greaves MF, and Weiss RA: The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature (London) 1984;312:763-767.
20. 20. Klatzmann D, Champagne E, Chamaret S, Gruest J, Guetard D, Hercend T, Gluckman J-C, and Montagnier L: T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature (London) 1984;312:767-770.
21. 21. Sattentau QJ, Dalgleish AG, Weiss RA, and Beverely PCL: Epitopes of the CD4 antigen and HIV infection. Science 1986;234: 1120-1123.
22. 22. Sattentau QJ, Arthos J, Deen K, Hanna N, Healey D, Beverley PCL, Sweet R, and Truneh A: Structural analysis of the human immunodeficiency virus-binding domain of CD4. Epitope mapping with site-directed mutants and anti-idiotypes. J Exp Med 1989;170: 1319-1334.
23. 23. Chanh TC, Dreesman GR, and Kennedy RC: Monoclonal anti-idiotypic antibody mimics the CD4 receptor and binds human immunodeficiency virus. Proc Natl Acad Sci USA 1987;84: 3891-3895.
24. 24. Reeves JP, Buck D, Berkower I, Murphy D, and Epstein SL: Anti-Leu 3a induces combining site related anti-idiotypic antibody without inducing anti-HIV activity. AIDS Res Hum Retroviruses 1991;7:55-63.
25. 25. Healey DG, Dianda L, Buck D, Schroeder K, Truneh A, Sattentau QJ, and Beverley PCL: A highly selected panel of anti-CD4 antibodies fails to induce anti-idiotypic antisera mediating human immunodeficiency virus neutralization. Eur J Immunol 1991;21: 1491-1498.
26. 26. McDougal JS, Nicholson JKA, Cross GD, Cort SP, Kennedy MS, and Mawle AS: Binding of the human retrovirus HTLV-III/ LAV/ARV/HIV to CD4 (T4) molecule: Conformation dependence, epitope mapping, antibody inhibition and potential for idiotypic mimicry. J Immunol 1986;137:2937-2944.
27. 27. Sutor GC, Dreikhausen U, Vahning U, Jurkiewicz E, Hunsmann G, Lundin K, and Schedel I: Neutralization of HIV-1 by anti-idiotypes to monoclonal anti-CD4: Potential for idiotype immunization against HIV. J Immunol 1992;149:1452-1461.
28. 28. Wilks D, Walker LC, Habeshaw JA, Webster ADB, and Dalgleish AG: Antiidiotypic responses to immunization with anti-Leu 3a in human immunodeficiency virus-seropositive individuals. J Infect Dis 1991;163:389-392.
29. 29. Dalgleish AG and Kennedy RC: Anti-idiotypic antibodies as immunogens: Idiotype-based vaccines. Vaccine 1988;6:215-220.
30. 30. Beverley PCL, Healey D, Broadhurst K, and Sattentau QJ: Limitations of the anti-idiotype strategy for an HIV vaccine. J Autoimmun 1989;2:243-249.
31. 31. Keay S, Wecksler W, Margolick SS, and Farzadegan H: Association between anti-CD4 antibodies and a decline in CD4+ lymphocytes in human immunodeficiency virus type 1 seroconverters. J Infect Dis 1995;171:312-319.
32. 32. Karpatkin S, Nardi MA, Liu LX, Kouri YH, and Borkowsky W: Production of a human anti-CD4 monoclonal antibody with anti-idiotype to anti-HIV type 1 glycoprotein 120. AIDS Res Hum Retroviruses 1995;11:509-515.
33. 33. Deckert PM, Ballmaier M, Lang S, Deicher H, and Schedel I: CD4-imitating human antibodies in HIV infection and anti-idiotypic vaccination. J Immunol 1996;156:826-833.
34. 34. Watanabe M, Boyson JE, Lord CI, and Letvin NL: Chimpanzees immunized with recombinant soluble CD4 develop anti-self CD4 antibody responses with anti-human immunodeficiency virus activity. Proc Natl Acad Sci USA 1992;89:5103-5107.
35. 35. Davis SJ, Schockmel GA, Somoza C, Buck DW, Healey DG, Rieber EP, Reiter C, and Williams AF: Antibody and HIV-1 gp120 recognition and CD4 undermines the concept of mimicry between antibodies and receptors. Nature (London) 1992;358:76-79.
36. 36. Healey DG, Dianda L, and Beverley PCL: A "network antigen" for human CD4: A murine monoclonal anti-idiotype to Leu-3a induces an anti-CD4 response in naive mice. J Immunol 1992;148: 821-826.
37. 37. Perosa F and Dammacco F: Human CD4 "internal antigen" mimicry by anti-idiotypic monoclonal antibodies. Int J Clin Lab Res 1994;24:33-40.
38. 38. Olive D and Mawas C: Therapeutic applications of anti-CD4 antibodies. Crit Rev Ther Drug Carrier Sys 1993;10;29-63.
39. 39. DeBoer RJ and Boucher CA: Anti-CD4 therapy for AIDS suggested by mathematical models. Proc R Soc Lond B Biol Sci 1996;263:899-905.
40. 40. Dhiver C, Olive D, Rousseau S, Tamalet C, Lopez M, Galindo JR, Mourens M, Hirn M, Gastaut JA, and Mawas C: Pilot phase I study using zidovudine in association with a 10 day course of anti-CD4 monoclonal antibody in seven AIDS patients. AIDS 1989;3:835-842.
41. 41. Reimann KA, Burkly LC, Burrus LC, Waite BC, Lord CI, and Letvin NL: In vivo administration to rhesus monkeys of a CD4-specific monoclonal antibody capable of blocking AIDS virus replication. AIDS Res Hum Retroviruses 1993;9:199-207.
42. 42. Reimann KA, Gate RL, Wu Y, Palmer L, Olson D, Waite BC, Letvin NL, and Burkly LC: In vivo administration of CD4-specific monoclonal antibody: Effect on provirus load in rhesus monkeys chronically infected with the simian immunodeficiency virus of macaques. AIDS Res Hum Retroviruses 1995;11:517-525.